440mg Hertraz Injection

About 440mg Hertraz Injection

Hertraz 440mg Injection contains Trastuzumab, a targeted cancer therapy used to treat HER2-positive breast cancer and HER2-positive metastatic gastric cancer. HER2-positive cancers produce excessive amounts of the HER2 protein, which promotes the rapid growth and spread of cancer cells. Trastuzumab works by specifically targeting and blocking these HER2 receptors, helping to slow tumor growth and improve treatment outcomes. HER2-positive breast cancer is often considered more aggressive than other breast cancer types, making targeted therapies like Hertraz an important part of treatment. Patients receiving Hertraz 440mg Injection should use effective contraception during treatment and for at least seven months after the final dose to avoid potential harm during pregnancy. This medication is not recommended for individuals under 18 years of age, patients with severe breathing difficulties, or those requiring oxygen therapy. Before starting treatment, patients should inform their healthcare provider about any history of heart disease, breathing problems, previous cancer treatments, or any medications, supplements, or herbal products they are currently taking. Regular medical monitoring may be required to ensure the safe and effective use of Hertraz 440mg Injection throughout the treatment period.

Comprehensive Cancer Treatment

440mg Hertraz Injection offers a specialized approach for individuals battling metastatic breast cancer. Utilizing the targeted action of Trastuzumab, it disrupts cancer cell growth, providing significant clinical benefits. This injectable medication is recommended by oncologists and is supported by solid evidence for its effectiveness in both hospital and clinical settings.


Trusted Indian Origin and Global Supply

Sourced directly from India, Hertraz Injection upholds high standards of manufacture and quality assurance. It is widely distributed by exporters and suppliers, making it readily accessible for healthcare facilities and eligible patients worldwide. The single 440mg vial packaging ensures accurate dosing and patient convenience.